USV Launches Empagliflozin Range Under Xenia Brand Deeksha Bhandari2 April 2025 12:23 PM ISTUSV Pvt. Ltd., a leader in diabetes care, has announced the launch of its Xenia brand range in India, following the patent expiry of Empagliflozin. ...
USV Expands Diabetes Portfolio with Cost-Effective Liralin-EP in India Deeksha Bhandari22 March 2025 1:00 PM ISTUSV Pvt. Ltd., launches the Liralin EP a combination of Linagliptin & Empagliflozin at just Rs 12.90 per tablet for strengthening it's affordable...
Spore-forming microbial whole-cell sensing strategy promising strategy against diabetes management: Study Jacinthlyn Sylvia8 March 2025 9:00 AM ISTA new study published in the journal of Nature Microsystems & Nanoengineering found that spore-forming microbial whole-cell sensing strategy to be...
AID beneficial and safe option for improving HbA1C among insulin-dependent type 2 diabetes patients: JAMA Dr Riya Dave20 Feb 2025 8:30 AM ISTA nonrandomized clinical trial found that HbA1c levels decreased in a diverse group of adults with type 2 diabetes after starting automated insulin...
Couple based therapy found beneficial for older adults with poorly controlled glycemia: JAMA Dr Riya Dave13 Jan 2025 9:15 AM ISTResearchers have found couple-based interventions useful for patients with uncontrolled type 2 diabetes (T2DM). Diabetes care tends to require...
GSK's Augmentin Leads Indian Pharma Market in October with Rs 843 Crore Sales: Pharmatrac Report Farhat Nasim22 Nov 2024 5:40 PM ISTNew Delhi: As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the test of time...
Study Reveals No Impact of Normal Vitamin B12 Levels on Diabetic Foot Ulcer Development Dr Riya Dave18 Oct 2024 9:00 AM ISTResearchers have reported that diabetic foot ulcer (DFU) is one of the major complications of diabetes, normal vitamin B12 levels seem to offer no...
GLP-1 Receptor Agonists Reduce Hyperkalemia and Enhance RASi Use in Type 2 Diabetes Dr Riya Dave1 Oct 2024 8:15 AM ISTResults of a recent study found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a lower risk for hyperkalemia, greater...
Micro Labs Launches Linapride DM: Affordable Diabetes Treatment in India MD Brand Connect2 Sept 2024 12:48 PM ISTUncontrolled Diabetes has become a major challenge in today's Diabetes Management and it keeps raising the bar. As per the ICMR-INDIAB Study...
Fenofibrate Cuts Diabetic Retinopathy Risk by 27%: LENS Trial Dr. Kamal Kant Kohli20 Aug 2024 12:16 PM ISTA groundbreaking trial presented for the first time at the ADA 2024 demonstrated that Fenofibrate significantly reduces the progression of diabetic...
New automated insulin delivery systems improve diabetes management: ADA Jacinthlyn Sylvia26 Jun 2024 7:00 AM ISTA new research highlights the significant benefits of advanced technological innovations in managing type 2 diabetes (T2D) was presented at the...
Glipizide-Metformin, Glimepiride-Metformin-Pioglitazone FDCs Reduce Medication Costs in Indian T2DM: Study Dr. Kamal Kant Kohli27 May 2024 11:30 AM ISTAffordable combination medicines, such as glipizide + metformin and glimepiride + metformin + pioglitazone offer considerable advantages and can...
